PDPK1

PDPK1

Target · Serine/threonine kinase

PDPK1 3-phosphoinositide-dependent protein kinase 1 · PDK1

PDPK1 (3-phosphoinositide dependent protein kinase 1, also known as PDK1) is a serine/threonine protein kinase of the AGC kinase family. It acts in intracellular signal transduction downstream of cell surface receptors and has been linked to prostate cancer and lung non-small cell carcinoma. Browse Assay Genie's current range of PDPK1 research reagents below, or read on for the biology behind the target.

Cytoplasm, nucleus and membraneAGC Ser/Thr protein kinaseLung NSCLC biomarker
556 aa
Protein length
~63 kDa
Molecular weight
16p13.3
Gene locus
EC 2.7.11.1
Enzyme class
Target information

What is PDPK1 (3-phosphoinositide dependent protein kinase 1)?

PDPK1 is a protein kinase that enables 3-phosphoinositide-dependent protein kinase activity. As a serine/threonine kinase (EC 2.7.11.1), it transfers phosphate groups to serine or threonine residues on its substrates. It also shows phospholipase binding and phospholipase activator activity. Gene annotation places it in several processes, including cell surface receptor signalling, the intracellular signalling cassette and the regulation of signal transduction, and it acts upstream of or within intracellular signal transduction.

The PDPK1 protein is found in several compartments. UniProt lists the cytoplasm, the nucleus, the cell membrane and focal adhesions at cell junctions, and NCBI Gene describes it as located in the cytosol and plasma membrane. It belongs to the protein kinase superfamily, in the AGC Ser/Thr protein kinase family and the PDPK1 subfamily. HGNC groups the gene in the 3-phosphoinositide dependent protein kinase 1 family. The human PDPK1 gene is on chromosome 16p13.3, and orthologues are annotated in mouse and rat, both named Pdpk1.

PDK1 is the alternative name used for this kinase in the literature, and it is recorded as a previous symbol in HGNC. In disease research, PDPK1 is implicated in prostate cancer and is described as a biomarker of lung non-small cell carcinoma. This makes the PDPK1 gene and its product a frequent subject in studies of kinase signalling and cancer biology.

Intracellular signal transduction

PDPK1 acts upstream of or within intracellular signal transduction and takes part in cell surface receptor signalling and the regulation of signal transduction.

Prostate cancer research

PDPK1 is implicated in prostate cancer, so it is studied in work on kinase signalling in this disease.

Lung cancer biomarker studies

PDPK1 is described as a biomarker of lung non-small cell carcinoma, which makes it relevant to biomarker and tumour biology research.

AGC kinase biology

As the namesake of the PDPK1 subfamily in the AGC Ser/Thr kinase family, it is a reference point for comparing related protein kinases.

Background

PDPK1 frequently asked questions

What does PDPK1 do?

PDPK1 is a serine/threonine protein kinase with 3-phosphoinositide-dependent protein kinase activity. It also binds phospholipases and activates them. It is involved in cell surface receptor signalling, the intracellular signalling cassette and the regulation of signal transduction.

Is PDPK1 the same as PDK1?

Yes. PDK1 is an alias and previous symbol for the gene now named PDPK1 by HGNC. The full name is 3-phosphoinositide dependent protein kinase 1. Both terms appear in the literature, so it helps to search under each when reviewing earlier work.

Is PDPK1 conserved in mouse and rat, and is it linked to disease?

Mouse and rat both have an orthologous gene named Pdpk1. In humans, PDPK1 is implicated in prostate cancer and is a biomarker of lung non-small cell carcinoma. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other AGC kinases, phosphoinositide signalling proteins and cancer-associated signalling targets that may be of interest alongside PDPK1.

Gene and protein annotations from HGNC, NCBI Gene and UniProt O15530; product specifications from Assay Genie datasheets.

PDPK1 Product listing